In an interview conducted at the 2024 American Society of Hematology Annual Meeting in San Diego, California, Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center,…
Systemic mastocytosis, a rare blood disorder, affects the entire body. There are many challenges associated with living with this systemic mastocytosis that are centered around reducing the frequency…
NEW YORK (Reuters Health) – An investigational drug called motavizumab may offer better protection against respiratory syncytial virus (RSV) than palivizumab in high risk children, according to a…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
NEW YORK (Reuters Health) – Anti-tumor necrosis factor (TNF) agents do not increase the risk of cancer during the first few years of use for rheumatoid arthritis, according…
NEW YORK (Reuters Health) – In a follow-up study of Alaska Natives who received plasma-derived hepatitis B vaccine when they were more than 6 months old, a large…
NEW YORK (Reuters Health) – Prophylactic use of acetaminophen during vaccination in children can reduce febrile reactions, but unfortunately the antibody responses to various vaccine antigens are weakened,…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
NEW YORK (Reuters Health) – In young women, the presence of lupus anticoagulant is associated with a more than 40-fold increased risk of stroke and 5-fold increased risk…
NEW YORK (Reuters Health) – There is “compelling evidence” for a benefit of statins in chronic obstructive pulmonary disease (COPD), but the evidence is not yet strong enough…
NEW YORK (Reuters Health) – During the 2007-2008 flu season, the licensed inactivated flu vaccine was 50% more effective than the live attenuated vaccine in preventing laboratory-confirmed symptomatic…
NEW YORK (Reuters Health) – New research from France indicates that patients using anti-tumor necrosis factor (TNF) monoclonal antibody therapy are at greater risk for developing tuberculosis than…
